The prion was defined by Stanley B. Prusiner as the infectious agent that causes transmissible spongiform encephalopathies.
Prevalence and clinical characteristics of prion diseases
Prion diseases or transmissible spongiform encephalopathies (TSEs) are neurological disorders, characterized by dementia and movement disorder. Histopathological changes of the brain comprise a fine vacuolation, also termed spongiosis, reactive changes of astrocytes (gliosis) and variable loss of neurons. Typical examples of TSEs in humans are CreutzfeldtJakob disease (Creutzfeldt, 1920) and Gerstmann-Str ausslerScheinker syndrome (Gerstmann et al. 1936 ) which were first described in the second and third decade of the 20th century. While the prototype of prion diseases in animals, scrapie in sheep and goats, has been known for more than two centuries, a new form of animal prion disease designated bovine spongiform encephalopathy (BSE) has since its first recognition in 1986 developed into an epizootic (Wilesmith et al. 1992; Anderson et al. 1996) . The emergence of a new variant form of Creutzfeldt-Jakob disease (nvCJD) in young people in the UK has raised the possibility that BSE has spread to humans by dietary exposure (Will et al. , 1999 . This fearful scenario has recently been supported by experimental evidence claiming that the agent causing BSE is indistinguishable from that causing nvCJD (Hill et al. 1997a ).
The molecular biology of prions
Although there is an increasing body of evidence, that the infectious agent of transmissible spongiform encephalopathies, the prion, partially or entirely consists of an abnormally folded protein Prusiner et al. 1983; Oesch et al. 1985) , the nature of this agent is still under debate. The possibility that the agent consists of viral particles can almost certainly be ruled out, since no nucleic acids have been detected. Since prions are distinguished from conventional agents by their physicochemical properties, the protein-only hypothesis has been formulated firstly by Griffith (1967) and later, supported by additional experimental data by Prusiner (1982) . He coined the term prion, composed from the words 'proteinaceous infectious agent'. The hypothesis states that the agent is devoid of nucleic acid and consists solely of an abnormal conformer of the cellular prion protein, PrP C . It has been proposed that the partially protease-resistant and detergent-insoluble PrP Sc is congruent with the infectious agent.
Two distinct models have been postulated to explain the mechanism by which a misfolded form of PrP could catalyse the refolding of native PrP molecules into the abnormal Since the latter discovery, transgenic mice have contributed many important insights into the field of prion biology, including the understanding of the molecular basis of the species barrier for prions. By disrupting the Prnp gene, it was shown that an organism that lacks PrP C is resistant to infection by prions. Introduction of mutant PrP genes into PrP-deficient mice was used to investigate the structure-activity relationship of the PrP gene with regard to scrapie susceptibility. Ectopic expression of PrP in PrP knockout mice proved a useful tool for the identification of host cells competent for prion replication. Finally, the availability of PrP knockout mice and transgenic mice overexpressing PrP allows selective reconstitution experiments aimed at expressing PrP in neurografts or in specific populations of haemato-and lymphopoietic cells. The latter studies have allowed us to clarify some of the mechanisms of prion spread and disease pathogenesis. Experimental Physiology (2000) 85.6, 705-712.
Publication of The Physiological Society * Corresponding author: seb@pathol.unizh.ch conformation and both models are the subjects of intensive investigation: (i) the template-directed model, and (ii) the nucleation-seeding model (Fig. 1) (Prusiner, 1991) . In this model PrP Sc would be intrinsically more stable than PrP C , but kinetically inaccessible. In the second model, formation of PrP Sc would be initiated by a seed of aggregated PrP Sc triggering a nucleation-dependent polymerization process (Jarrett & Lansbury, 1993 molecules. An important corollary to this hypothesis is that an organism lacking PrP C should be resistant to scrapie and unable to propagate the infectious agent. To this end, B ueler and colleagues generated mice with a targeted disruption of the Prnp gene (B ueler et al. 1992) . Although the ubiquitous expression of PrP in the developing and adult central nervous system (CNS) suggested a significant role in development and function of the CNS, the resulting mice showed no overt phenotype. In particular, they show no developmental defects, no behavioural abnormalities and have a normal life expectancy. Intracerebral inoculation of these mice with prions revealed that they were resistant and did not propagate the agent, thereby verifying the prediction of the protein-only hypothesis (B ueler et al. 1993; Sailer et al. 1994 ). Heterozygous mice with only one disrupted allele (Prnp + Ï0
) also showed partial resistance to scrapie infection as manifested by prolonged incubation times of about 290 days compared with about 160 days in Prnp +Ï+ mice (B ueler et al. 1994 ). This suggests that the amount of PrP C protein in the brain is a rate-limiting step in the development of the disease may point to therapeutic efforts aimed at reducing the production of the normal PrP C isoform.
Prion neurotoxicity: the neurografting approach
What is the pathogenetic event that impairs the central nervous system? It is a common belief, that deposits of pathological prion protein are to blame by inducing neuronal cell death (Fairbairn et al. 1994; Giese et al. 1995) , and among several possible factors are elevated cytokine levels in the brain (Campbell et al. 1994; Williams et al. 1994 ). To clarify, whether or to what extent prions are directly neurotoxic, we introduced a transplant which continuously delivered PrP Sc into the brains of Prnp 0Ï0 mice. This was accomplished by grafting neural tissue overexpressing PrP into the brain of PrP-deficient mice (Fig. 2) . After intracerebral inoculation with scrapie prions, these grafts not only developed severe signs of neurodegeneration ( Fig. 3) (Brandner et al. 1996 (Brandner et al. , 1998 but also accumulated high levels of PrP Sc and infectivity. Substantial amounts of graft-derived PrP Sc migrated even into distant areas of the host brain which then contained substantial amounts of infectivity. But surprisingly, these brain areas did not show pathological changes, not even in the immediate vicinity of the grafts or the PrP deposits ( Fig. 3) (Brandner et al. 1996) . We concluded that PrP Sc is inherently non-toxic and PrP Sc plaques found in spongiform encephalopathies may be an epiphenomenon rather than a cause of neuronal damage. It is conceivable that PrP Sc is only toxic when it is formed and accumulated within the cell but not when presented from outside. Results from other researchers suggest that microglia may play a certain role in mediating the toxic effect from PrP Sc on PrP C -expressing neurons.
The neuroinvasion of prions
Although the intracerebral application is by far the most effective route for prion infection, oral uptake is the epidemiologically more relevant. This route is thought to be responsible for the transmission not only of BSE but also of new variant CJD (Hill et al. 1997b ). Since prion diseases primarily manifest as a disease of the CNS, invasion of prions from the periphery must be of crucial importance and, considering the precision of incubation times even after intraperitoneal inoculation, are tightly controlled. We therefore set out to elucidate the mechanisms of prion spread from periphery to the CNS. In a first set of experiments, we asked whether prions can migrate from the periphery to a graft in the CNS of a Prnp 0Ï0 mouse: intraperitoneal inoculation of such grafted Neuroinvasion of prions: insights from mouse models Exp. Physiol. 85.6 707 Figure 2 Schematic drawing of the transplantation procedure to obtain PrP-expressing grafts within the brain of Prnp 0Ï0 mice. Transgenic mice overexpressing PrP (termed tga20) were mated and embryos were removed at day 13.5. The neuroectodermal brain anlage was removed and transplanted into the brain of an adult recipient (Prnp 0Ï0 ) mouse, where it differentiates into mature neuroectoderm. Inoculation with prions was carried out at various time points after transplantation. mice did not provoke any disease in the graft and did not result in accumulation of prions in the spleen (Bl attler et al. 1997) . In contrast, wild-type mice develop scrapie and accumulate high titres of infectivity in the lymphoreticular system, shortly after intraperitoneal or intracerebral inoculation. Then we asked, whether transfer of wild-type bone marrow to into prnp 0Ï0 mice would restore prion replication. First, Prnp 0Ï0 mice received intracerebral grafts of Prnp overexpressing cells which eventually serves as an indicator for infectivity brought into the CNS. Then, these mice were irradiated and received bone marrow from wild-type mice. After peripheral prion infection, there was infectivity detectable in the spleen, but surprisingly no disease in the CNS graft. We concluded, that the transport from the spleen to the CNS requires another tissue compartment, which is not restored by bone marrow reconstitution (Bl attler et al. 1997) . A possible candidate is the peripheral nervous system, as suggested by indirect findings.
The role of the lymphoreticular system in the neuroinvasion of prions Several studies indicate an important role of lymphoid organs in prion replication, but there is little knowledge about which cells support prion propagation in the lymphoreticular system. Whole-body ionizing radiation studies in mice after intraperitoneal infection have suggested that the critical cells are long lived (Fraser & Farquhar, 1987) . Follicular dendritic cells (FDCs) are possible candidates (Kitamoto et al. 1991) , and S. Brandner and others Exp. Physiol. 85.6 708 Figure 3 Non-infected neural grafts in brains of Prnp 0Ï0 mice. Upper row (a-d), healthy control graft 230 days after mock inoculation. The graft is located in the third ventricle of the recipient mouse (a, see asterisks, haematoxylin-eosin), and shows no spongiform change, little gliosis (b, immunostain for glial fibrillary acidic protein (GFAP)), and strong expression of synaptophysin (c) and of PrP C (d). Middle row (e-h), scrapie infected graft 235 days after inoculation with increased cellularity (e), brisk gliosis (f) and a significant loss of synaptophysin (g) and PrP (h) staining intensity is shown. Bottom row, high magnification of a similar chronically infected graft shows characteristic pathological changes. i, appearance of large vacuoles and ballooned neurons (arrow). In the GFAP immunostain (j), astrocytes appear wrapped around densely packed neurons. Glandular deposits and intracytoplasmic accumulation of synaptophysin (k) and PrP immunoreactivity (l) in the cytoplasm of neurons.
indeed PrP Sc accumulates in these cells of wild-type mice and in mice with a selective T cell defect. Further evidence for the importance of follicular dendritic cells came from experiments with severe combined immunodeficiency (SCID) mice whose FDCs are thought to be functionally impaired. In these mice, intraperitoneal infection does not lead to replication of prions in the spleen nor in the CNS. Reconstitution of SCID mice with wild-type spleen cells restores susceptibility to scrapie after peripheral infection (Fraser et al. 1996) . These findings suggest that components of the immune system are required for efficient transfer of prions from the periphery to the CNS. Thus, we analysed the role of other components of the immune system which may contribute to neuroinvasion of prions. We used mice with genetically engineered selective inactivation of specific component of the immune system. We used mice with defects of B and T cells ( T cell subsets. Isolated T cell defects were investigated with CD4 −Ï− , CD8 −Ï− , âµ-microglobulin-or Perforin-deficient mice. We found that defects affecting T cells had no apparent effect on the incubation time after i.p. inoculation while all mutations that disrupted the differentiation of B cells prevented the development of clinical scrapie in i.p. inoculated mice (Fig. 4A) . Intracerebral inoculation of all these mice, however, did not reveal any difference between the different groups (Fig. 4B) . These results seem to indicate a crucial role for B cells in the propagation of scrapie after peripheral infection (Klein et al. 1997 ). However, since mice devoid of B cells fail to produce antibodies, and FDCs fail to develop in their lymphoid organs, we asked which of these three factors might be responsible for prion pathogenesis. Thus two further mouse strains were investigated. To elucidate the role of immunoglobulins we analysed mice producing antibody exclusively of the IgM subclass (t11 ìMT), which had no detectable specificity for PrP C . The role of FDCs was addressed using mice that lacked functional FDCs (TNFR1 −Ï− ) but have differentiated B cells. Both strains developed scrapie after peripheral inoculation and again supported the notion of a crucial role for differentiated B cells in neuroinvasive scrapie (Klein et al. 1997 ).
PrP expression in B cells is not necessary for prion neuroinvasion
Replication of prions and their transport from the periphery to the CNS relies on the expression of PrP C on lymphocytes. Thus we further asked, whether expression of PrP C on B cells was a prerequisite for neuroinvasion of prions. Again, mice with various immune defects (SCID, RAG 1 −Ï− and ìMT −Ï− ) were used for adoptive transfer of fetal liver cells either from wildtype or from Prnp 0Ï0 mice. This reconstitution induced the formation of germinal centres in spleens of all mice, including differentiation of FDCs. As control, we used B and T celldeficient mice reconstituted with FLCs from (B cell-deficient) ìMT embryos, and found no follicular dendritic cells in accordance with the notion that B cells or products thereof are required for FDC maturation. Reconstituted mice were challenged i.p. with scrapie prions. Surprisingly, all mice that received FLCs of either genotype, Prnp +Ï+ or Prnp 0Ï0 , from immunocompetent donors developed scrapie after inoculation with a high dose of prions, and most mice after a low dose. Transfer of FLCs from ìMT donors, as well as omission of the adoptive transfer procedure, did not restore susceptibility to disease in any of the immunodeficient mice challenged with the low dose. In a further step we asked whether spleen PrP was associated with FDCs in FLC reconstituted mice. With double-colour immunofluorescence confocal microscopy we detected deposits of PrP-immunoreactive material in germinal centres in spleens of reconstituted mice which largely co_localized with the follicular dendritic network (Fig. 5 ) (Klein et al. 1998 ). These results support our notion that cells whose maturation depends on B cells are responsible for accumulation of prions in spleen. The most likely candidates are FDCs, since their maturation correlates with the presence of B cells and the formation of immune complexes. On the other hand, it is equally possible that the follicular dendritic network serves as a reservoir for the accumulation and multiplication of prions. Other B cell-dependent processes could enable the transfer of prions to autonomic nerve terminals or the agent may be transported on or within B cells directly within peripheral lymphoid tissue. Alternatively, antibodies or other factors may bind prions, especially since PrP can be detected by immunohistochemical stains in the germinal centre area where immune complexing occurs, and this formation may be of importance for mediating neuroinvasion and facilitating the access to peripheral nervous system terminals.
Current threats and future perspectives
What are the implications of the above findings in the framework of the current epidemics of BSE and the occurrence of nvCJD? For one thing, there is some evidence that nvCJD is more lymphotropic than sporadic CJD, since nvCJD but not sporadic CJD prions have been detected in tonsils and appendix. Therefore understanding the peripheral pathogenesis is of immediate importance in assessing risks of iatrogenic transmission of human BSE via exposure to blood or tissues from preclinical cases, and possibly from contaminated surgical instruments, or even blood and blood products. It is unfortunate that little is known about the distribution of preclinical disease in the UK, leaving the actual persistence of the agent in the population entirely obscure. What is particularly unsettling about this lack of knowledge is the fact that sensitive and reliable assays are now available for detection of PrP Sc in lymphatic tissues of cadavers, and these assays have been shown to constitute reliable indicators of nvCJD. Given that the most problematic aspect in public health decision-making is the uncertainty in prevalence of subclinical disease, the use of such assays for unlinked anonymous surveys of post-mortem material would seem to be logical, imperative and extremely urgent for planning measures aimed at limiting the spread of nvCJD among humans. Our results indicate that follicular dendritic cells are most probably the prion reservoir in lymphatic organs but also splenic lymphocytes of experimentally inoculated mice can be infected with prions. This finding raises an alert, because blood lymphocytes might well be in equilibrium with their splenic counterparts and may be relevant if blood donors are subclinical carriers of the nvCJD agent . However, there are still controversies as to whether depletion of leucocytes in blood products is necessary andÏor sufficient to effectively prevent any possible risk. Another consideration applies to secondary prophylaxis. As mentioned above, there might be a considerable number of preclinically infected people (Aguzzi & Collinge, 1997) who may have acquired infectious BSE material via the human food chain. It is a pressing issue to develop approaches that will help control spread of the agent and that will hopefully prevent the clinical outbreak of symptoms in these persons. In light of the above findings, possible targets for the interference with neuroinvasion are rate-limiting processes that control prion replication within the infected individual. In light of the knowledge discussed above, treatments that target the neuroimmune interface of prion replication and neuroinvasion seem a promising area for research aimed at post-exposure prophylaxis.
